Aurora Spine Corporation : AURORA SPINE ANNOUNCES FIRST SURGERY USING ZIP GRAFT(TM) BONE DOWEL

Carlsbad, California, July 25, 2014 /Marketwired/ - Aurora Spine Corporation (TSX VENTURE:ASG) announced today the first U.S. surgery using the ZIP Graft (TM) pre-packaged sterile bone dowel. The surgery was performed at Madison County Hospital in London, Ohio by Dr. Won Song.

The Aurora Zip Graft is a bone dowel designed specifically to fit into the ZIP(TM) MIS Interspinous Fusion System.  "We are very excited to see the Zip Graft used in conjunction with the Zip MIS fusion device. The allograft bone dowels are designed and sized to fit into our devices thus creating an integrated fit every time" stated Doug Johnson VP of Sales, East.

The Aurora ZIP Graft is a cancellous allograft, available in various sizes, designed to specifically fit into the ZIP MIS Interspinous Fusion System. ZIP Graft is gamma irradiated and packaged sterile for immediate use.

Originally released in Europe as a pre-packaged sterile synthetic bone dowel composed of tri-calcium phosphate, available for international use only, ZIP Graft will also be continuously commercialized throughout Europe.

About Aurora Spine

Aurora Spine is an early stage company focused on bringing new solutions to the spinal implant market through a series of innovative, minimally invasive, regenerative spinal implant technologies.

Forward-Looking Statements

This news release contains forward-looking information that involves substantial known and unknown risks and uncertainties, most of which are beyond the control of Aurora Spine, including, without limitation, those listed under "Risk Factors" and "Cautionary Statement Regarding Forward-Looking Information" in Aurora Spine's final prospectus (collectively, "forward-looking information"). Forward-looking information in this news release includes information concerning the proposed use and success of Aurora Spine's products in surgical procedures. Aurora Spine cautions investors of its securities about important factors that could cause Aurora Spine's actual results to differ materially from those projected in any forward-looking statements included in this news release. Any statements that express, or involve discussions as to, expectations, beliefs, plans, objectives, assumptions or future events or performance are not historical facts and may be forward-looking and may involve estimates, assumptions and uncertainties which could cause actual results or outcomes to differ unilaterally from those expressed in such forward-looking statements. No assurance can be given that the expectations set out herein will prove to be correct and, accordingly, prospective investors should not place undue reliance on these forward looking statements. These statements speak only as of the date of this press release and Aurora Spine does not assume any obligation to update or revise them to reflect new events or circumstances.

For more information, please contact:

Aurora Spine Corporation

Trent Northcutt
President and Chief Executive Officer
(760) 424-2004